Ben Harshbarger Named Chief Legal Officer of Xilio Therapeutics

Ben Harshbarger was named Chief Legal Officer of Xilio Therapeutics on June 29, 2026, according to GlobeNewswire.

NameBen Harshbarger
RoleChief Legal Officer
CompanyXilio Therapeutics
IndustryBiotechnology
LocationWaltham, MA
MoveAppointment
DateJune 29, 2026
SourceGlobeNewswire

Xilio Therapeutics appointed Ben Harshbarger as chief legal officer. He most recently was chief legal officer of Astria Therapeutics through its acquisition by BioCryst, and before that served as interim CEO and general counsel at Novelion Therapeutics. (Source: GlobeNewswire.)

Who is the Chief Legal Officer of Xilio Therapeutics?

Ben Harshbarger took the Chief Legal Officer role at Xilio Therapeutics in June 2026, as reported by GlobeNewswire. Legal leadership changes often, so check Xilio Therapeutics’s own leadership page for the latest. If you know of a newer move, tell us and we will update the directory.

More legal leadership moves at Xilio Therapeutics

Other general counsel moves in June 2026

Browse every appointment in the General Counsel Directory.

Source: GlobeNewswire. InhouseBlog summarizes publicly reported general counsel moves and links to the original report.

Does this information need updating? Email us at info@inhouseblog.com.